Erica Rossitto - 06 Nov 2026 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Nov 2026, 17:09:24 UTC
Prior SEC filing
12 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kevin A. Ball, Attorney-in-Fact
Filing notes and source

Key filing fact

Erica Rossitto filed Form 4 for HCA Healthcare, Inc. (HCA) on 10 Nov 2026.

Key facts

  • This page summarizes Erica Rossitto's Form 4 filing for HCA Healthcare, Inc. (HCA).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 10 Nov 2026, 17:09.

Change

  • Previous filing in this sequence was filed on 12 Feb 2026.
  • Current net transaction value: -$1,770,335.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002108748 Primary reporting owner

Rossitto Erica

Relationship
SVP & Chief Nurse Executive
Address
ONE PARK PLAZA, NASHVILLE
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Signature date
10 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCA transaction

Common Stock

Options Exercise

Transaction value
Shares
+8,080
Change %
+78%
Price
$81.96*
Shares after
18,487
Date
06 Nov 2026
Ownership
Direct
HCA transaction

Common Stock

Options Exercise

Transaction value
Shares
+5,040
Change %
+27%
Price
$101.16*
Shares after
23,527
Date
06 Nov 2026
Ownership
Direct
HCA transaction

Common Stock

Tax liability

Transaction value
Shares
-6,601
Change %
-28%
Price
$494.99*
Shares after
16,926
Date
06 Nov 2026
Ownership
Direct
HCA transaction

Common Stock

Sale

Transaction value
-$1,770,335
Shares
-3,500
Change %
-21%
Price
$505.81
Shares after
13,426
Date
10 Nov 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HCA transaction Derivative

Stock Appreciation Right

Options Exercise

Transaction value
Shares
-8,080
Change %
-100%
Price
$0.000000*
Shares after
0
Date
06 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,080
Exercise price
$81.96
Footnotes
F1
HCA transaction Derivative

Stock Appreciation Right

Options Exercise

Transaction value
Shares
-5,040
Change %
-100%
Price
$0.000000*
Shares after
0
Date
06 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,040
Exercise price
$101.16
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.

Footnote F2

The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .